^
No biomarker
Meningioma
bevacizumab + everolimus
Sensitive: A2 - Guideline
No biomarker
Meningioma
bevacizumab
Sensitive: A2 - Guideline
No biomarker
Meningioma
sunitinib
Sensitive: A2 - Guideline
No biomarker
Meningioma
DG3173
Sensitive: A2 - Guideline
RB1 mutation
Meningioma
palbociclib
Sensitive: D – Preclinical
KLF4 K409Q
Meningioma
temsirolimus
Sensitive: D – Preclinical